Literature DB >> 1806490

Effects of human growth hormone on body composition in elderly men.

D Rudman1, A G Feller, L Cohn, K R Shetty, I W Rudman, M W Draper.   

Abstract

Body composition changes progressively in mid and late adulthood. Lean body mass in men over 50 years old contracts at an average rate of -0.6% per year. Body weight tends to remain stable because of a reciprocal expansion of adipose mass. The shrinkage of the lean body mass reflects the atrophy of skeletal muscles, skin and visceral organs. Because growth hormone causes expansion of the lean body mass and contraction of the adipose mass, and because growth hormone secretion tends to diminish in late adulthood, it has been postulated that geriatric hyposomatotropism is a contributory cause to the body composition changes described above. The authors have tested this hypothesis by recruiting 45 independent men over 61 years old with plasma somatomedin C level below 0.35 U/ml, indicating little or no detectable growth hormone secretion. The 21-month protocol was as follows: baseline period 0-6 months, experimental period 6-18 months and post-experimental period 18-21 months. During the experimental period, 26 men (group I) received approximately 0.03 mg/kg of biosynthetic human growth hormone (hGH) subcutaneously 3 times a week, while 19 men (group II) received no treatment. Plasma somatomedin C was measured monthly. The following outcome variables were measured at 0, 6, 12 and 18 months: lean body mass, adipose mass, skin thickness (dermis plus epidermis), sizes of the liver, spleen and kidneys, the cross sectional areas of ten muscle groups, and bone density at 9 skeletal sites. Lean body mass and adipose mass were also measured at 21 months. In group I, hGH treatment raised the plasma somatomedin C level and maintained it in the range 0.5-1.5 U/ml.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1806490     DOI: 10.1159/000182193

Source DB:  PubMed          Journal:  Horm Res        ISSN: 0301-0163


  16 in total

Review 1.  Obesity and related consequences to ageing.

Authors:  Magdalena Jura; Leslie P Kozak
Journal:  Age (Dordr)       Date:  2016-02-04

2.  Prepubertal gynecomastia a rare complication of growth hormone therapy.

Authors:  Shrikrishna V Acharya; Raju A Gopal; Tushar R Bandgar; Padma S Menon; Nalini S Shah
Journal:  Indian J Pediatr       Date:  2010-02-08       Impact factor: 1.967

3.  Growth hormone, IGF-I, and the elderly. Clues to potential therapeutic interventions.

Authors:  C J Rosen
Journal:  Endocrine       Date:  1997-08       Impact factor: 3.633

4.  Simultaneous stimulation of slow-wave sleep and growth hormone secretion by gamma-hydroxybutyrate in normal young Men.

Authors:  E Van Cauter; L Plat; M B Scharf; R Leproult; S Cespedes; M L'Hermite-Balériaux; G Copinschi
Journal:  J Clin Invest       Date:  1997-08-01       Impact factor: 14.808

Review 5.  Claims for the anabolic effects of growth hormone: a case of the emperor's new clothes?

Authors:  M J Rennie
Journal:  Br J Sports Med       Date:  2003-04       Impact factor: 13.800

6.  Influence of exogenous porcine growth hormone on vitamin D metabolism and calcium and phosphorus absorption in intact pigs.

Authors:  I Denis; M Thomasset; A Pointillart
Journal:  Calcif Tissue Int       Date:  1994-06       Impact factor: 4.333

7.  [Bacterial osteitis. Special considerations in immunocompromised patients].

Authors:  C Niedhart; O Miltner; K-W Zilkens; F U Niethard
Journal:  Orthopade       Date:  2004-03       Impact factor: 1.087

Review 8.  Regulation of muscle mass by growth hormone and IGF-I.

Authors:  C P Velloso
Journal:  Br J Pharmacol       Date:  2008-06       Impact factor: 8.739

9.  Treating age-related changes in somatotrophic hormones, sleep, and cognition.

Authors:  M V Vitiello; R S Schwartz; K E Moe; G Mazzoni; G R Merriam
Journal:  Dialogues Clin Neurosci       Date:  2001-09       Impact factor: 5.986

Review 10.  Hormonal and Metabolic Changes of Aging and the Influence of Lifestyle Modifications.

Authors:  Mark W Pataky; William F Young; K Sreekumaran Nair
Journal:  Mayo Clin Proc       Date:  2021-03       Impact factor: 7.616

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.